Twist Bioscience Corp. TWST 深 沪
已收盘 04-02 16:00:00 美东时间
50.21
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 50.21
- 总市值 282.50万
- 52周最高 57.88
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 23.30
- 委 比 0.00%
- 总股本 5.63万
- 历史最高 214.07
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.10
- 每 手 1
- 风险率 6.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多The Insider Report: The Two Way Tape Continues as Bears Hold Firm
Market Overview Stocks finished lower last week after a poor market response po...
03-01 22:47
ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025
ARK's 2025 winners included Robinhood, AMD and Palantir, while its losers were The Trade Desk, Recursion and Twist.
02-25 04:52
Twist Bioscience Licenses Invenra's B‑Body Platform To Expand Antibody Discovery Services
B-Body® platform complements Twist's antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeuticsPlatform to power high-throughput
02-17 20:09
Twist Bioscience Rolls Out Twist TrueAmp Library Presentation Kit, Twist PCR-Free WGS Preparation Kit
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twist PCR-Free WGS Library Preparation Kit, each designed to address a
02-10 21:09
Earnings Breakdown: Twist Bioscience Q1
Twist Bioscience (NASDAQ:TWST) released its Q1 earnings on Monday, February 2, ...
02-02 20:26
Twist Bioscience Sees Q2 Sales $107.000M-$108.000M vs $105.838M Est
For the second quarter,Twist expects Total revenue of approximately $107 million to $108 million, growth of approximately 16% percent year over year at the midpoint, with sequential growth driven by key NGS accounts
02-02 20:21
Twist Bioscience Raises FY2026 Sales Guidance from $425.00M-435.00M to $435.00M-440.00M
For the full fiscal year 2026, Twist expects: Total revenue in the range of $435 million to $440 million, growth of 16% at the midpoint, compared to prior guidance of $425 to $435 million. We expect the revenue
02-02 20:19
Earnings Scheduled For February 2, 2026
Companies Reporting Before The Bell • Revvity (NYSE:RVTY) is estimated to repor...
02-02 19:11
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses
Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.
2025-11-15 00:29
Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings
Twist Bioscience Corporation (NASDAQ:TWST) will release fourth-quarter earnings...
2025-11-14 15:35
